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Background and aims: Our aim was to evaluate the utility of endoscopic obliterative therapy 
with Histoacryl for gastric varices and to investigate the incidence of serious complications.
Methods: Endoscopic obliterative therapy with Histoacryl was performed on 129 gastric 
variceal patients. Sixty-five patients had cardiofornical varices, and 64 had fundal varices. 
Forty-five of 129 patients were emergency cases and the other 84 patients were prophylactic 
cases. Endoscopic therapy was performed under fluoroscopy using 70% Histoacryl (Histoacryl 
diluted with 5% Lipiodol).
Results: Endoscopic hemostasis of gastric varices was successful in 45/45 (100%) emergency 
cases. The recurrence rate of gastric varices was 17/120 (14.2%) among patients whose variceal 
eradication was achieved. Additional treatment was successfully performed in all recurrent cases. 
The incidence of serious complications was 4/129 (3.1%), including two cases of splenic infarc-
tion, one case of pulmonary embolism, and one case of an inflammatory tumor of   pancreatic 
tail. The two patients with splenic infarction improved with conservative medical treatment. The 
patient with pulmonary embolism showed no respiratory symptoms, and died of liver failure. 
The patient with the pancreatic tumor, which was diagnosed as an inflammatory tumor, was 
treated surgically.
Conclusions: Endoscopic obliterative therapy with Histoacryl is a useful and relatively safe 
method for treatment of bleeding gastric varices. Nonetheless, careful attention must be paid 
to avoid potentially serious complications.
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Introduction
Endoscopic treatments for bleeding esophageal varices, including endoscopic 
injection sclerotherapy and endoscopic variceal ligation, are accepted worldwide 
today. Bleeding gastric varices can also be treated successfully by injection of 
cyanoacrylate.
N-butyl-2-cyanoacrylate (Histoacryl, B.Braun Dexon GmbH Spangenberg, 
Germany) is a tissue glue monomer that polymerizes and solidifies instantly 
upon contact with blood. Soehendra et al were the first to report the usefulness 
of Histoacryl in the treatment of bleeding gastric varices,1 which have a high 
  mortality rate. Endoscopic obliterative therapy with Histoacryl, although useful 
for treating bleeding gastric varices,2–6 has drawbacks that include embolic and 
septic complications.
In this study, we report on the therapeutic effects and serious complications 
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Methods
Patients
One hundred twenty-nine patients with gastric varices and 
portal hypertension who underwent endoscopic   obliteration 
therapy with Histoacryl were evaluated   retrospectively 
(76 men and 53 women; age range, 30–81 years; mean, 
61.5 years). Among these patients, 45 were emergency cases 
and the other 84 were prophylactic cases; 55 patients were 
  classified as Child-Pugh class A, 30 as class B, and 44 as 
class C. The pathology underlying portal hypertension was 
liver cirrhosis (LC) in 84 patients, cirrhosis associated with 
hepatocellular carcinoma (HCC) in 31 patients, primary   biliary 
cirrhosis in four patients, idiopathic portal   hypertension in five 
patients, and other diseases in five patients. LC was confirmed 
by a   combination of clinical, biochemical, and ultrasound 
criteria, and HCC was diagnosed using imaging and biopsy. 
  Etiologies of cirrhosis in the 115 cases included 22 with hepa-
titis B surface antigen (HBsAg) positivity, 67 with hepatitis C 
virus (HCV) positivity, 21 with alcoholic liver disease, and 5 
unknown. The study was performed according to the tenets of 
the Declaration of Helsinki, and was approved by the Ethics 
Committee at Sapporo Kosei Hospital. Written informed con-
sent was obtained from all patients prior to the procedure.
Endoscopic findings
Endoscopic findings were evaluated according to the general 
rules for recording endoscopic findings of esophago-gastric 
varices established by the Japanese Research Society on 
  Portal Hypertension.7 The variceal form was classified as 
small and straight (F1), enlarged and tortuous (F2), or large and 
  coil-shaped (F3). Variceal location was classified as cardiac 
(Lg-c, located adjacent to the cardiac orifice), fundal (Lg-f, 
located far from the cardiac orifice), or cardiac and fundal 
(Lg-cf, located between the cardiac orifice and the fornix). The 
red color sign (RC) referred to dilated, small   vessels or telangi-
ectasia on the variceal surface. Among the 129 patients, 94 had 
F2 type and 35 had F3 type varices. Locations of varices were 
Lg-f in 64 patients and Lg-cf in 65. Fourteen patients among 
the 129 had RC-positive varices, whereas 25 showed erosion 
of the variceal surface. Sixteen of the 129 patients were also 
afflicted with esophageal varices. Using computed tomogra-
phy (CT), gastric varices were detected in all 129 patients and 
gastro-renal shunt as vessels flowing out of the gastric varices 
were detected in 107 of the 129 patients (83.0%).
Methods
In 45 emergency cases, endoscopic examination was 
  performed after stabilizing the general condition of the 
patients. When spurting or oozing bleeding, a red or white 
plug, or tiny erosion was observed (gastric varices) during 
emergency endoscopic examination (Figure 1a), endoscopic 
obliteration therapy using Histoacryl for hemostasis was 
performed immediately. Prophylactic endoscopic obliteration 
therapy using Histoacryl was performed on the remaining 
84 patients due to a high risk of bleeding. Risk of bleeding 
was determined by the presence of varices that enlarged 
in a short time, showed red color sign or erosion on their 
surface or showed high gastric blood flow velocity and thin 
gastric wall thickness to submucosal gastric varices using 
endoscopic color Doppler ultrasonography.
For endoscopic obliterative therapy for gastric varices, 
we used Histoacryl diluted to a final concentration of 70% in 
5% Lipiodol (Guerbert, Roissy, France). Lipiodol prevents 
the tissue adhesive from polymerizing too quickly and also 
allows for radiographic monitoring. Obliterative therapy 
was performed repeatedly with a 23-gauge needle until 
gastric varices disappeared. Fluoroscopic observation with 
an   infusion of 70% Histoacryl (avoiding flow into systemic 
circulation) was performed to determine the extent of the 
varices (Figure1b). Gastric variceal recurrence was defined 
by red color sign on variceal surface or variceal bleeding.
Results
Using endoscopy, ten of 45 emergency cases showed active 
bleeding from gastric varices, whereas a fibrin plug or erosion 
of the variceal surface was detected in the other 35 patients. 
Endoscopic hemostasis was successful in 45/45 (100%) in 
emergency cases.
Figure 1a image of a white plug observed on gastric varices during emergency 
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Eradication of gastric varices was achieved in 120 of 
129 (93.0%) patients. Among these patients, the number 
of endoscopic treatments required for variceal eradication 
varied from one to six (two patients with one session, 63 
with 2 sessions, 51 with 3 sessions, and 4 with four to six 
sessions). Total amount of Histoacryl ranged 1.5–8.0 mL; 
mean, 3.2 mL) in these 129 cases.
Varices reoccurred in 17 of the 120 patients (14.2%) in 
whom eradication was achieved, including 9/45 (20.0%) emer-
gency cases and 8/75 (10.7%) prophylactic cases.   Additional 
treatment was performed successfully in most cases.
The rate of serious complications related to the   procedure 
was 4/129 (3.1%), and included one case of pulmonary 
  embolism, one case of an inflammatory tumor of the 
  pancreatic tail, and two cases of splenic infarction. Total 
amount of Histoacryl was 2.5–8.0 mL (mean 4.3 mL) in 
these 4 cases. Using CT, gastric varices and gastro-renal 
shunt were detected in these 4 patients.
Both patients (F3, Lg-cf varices, see Figure 2a) with 
splenic infarction experienced persistent pain in their left upper 
quadrant immediately after injection, and developed a fever 
of 38 °C within five hours. We performed   obliterative therapy 
using 70% Histoacryl under fluoroscopy (three times with a 
2.5 mL total volume of Histoacryl (Figure 2b) in one case, 
and two times with a 2.5 mL volume in the other case). CT 
demonstrated large infarctions (70% in one case, and 90% in 
the other case, see Figure 2c) in the spleen. During hospitaliza-
tion, white cell and platelet counts rose to two to three times 
above normal levels within 14 days. Fever and abdominal pains 
subsided gradually to full recovery with only conservative 
medical treatment and antibiotics in these 2 cases.
The patient (F3, Lg-cf varices) who developed a 
  pulmonary embolism underwent four sessions endoscopic 
obliterative therapy under fluoroscopy, receiving a total of 
8.0 mL Histoacryl due to varices of large size. Five hours 
later, the patient developed a fever of 38 °C and chest 
  radiographs showed unusual nodular radiopaque pulmonary 
emboli along the pulmonary vessels. This patient showed no 
respiratory symptoms and died of liver failure with HBsAg 
positive liver cirrhosis.
Two years after endoscopic obliterative therapy using 70% 
Histoacryl, one patient developed an inflammatory tumor 
of the pancreatic tail, which we noted as a   possible compli-
Figure 1b Image of fluoroscopic observation with infusion of 70% Histoacryl to 
determine the extent of the varices.
Figure 2 A) Endoscopic image that reveals F3, Lg-cf varices with erosion. B) image 
of endoscopic obliterative therapy under fluoroscopy using 70% Histoacryl in this 
patient.
Abbreviations: GV, gastric varices; GrS, gastro-renal shunt.
Figure  2c  Five  days  after  obliterative  therapy,  CT  images  demonstrate  large 
infarctions encompassing 90% of the spleen. 
Abbreviations: GV, gastric varices; SPA, splenic artery; SPV, splenic vein.Clinical and Experimental Gastroenterology 2010:3 submit your manuscript | www.dovepress.com
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cation of the therapy. Endoscopic therapy was   performed 
during two sessions using the total amount of Histoacryl 
being 4.0 mL.
Following CT and endoscopic ultrasonography (EUS), 
we performed surgery on the patient. Histopathological 
examination of the resected tumor revealed an encapsuled 
abscess formation with foreign body reaction and necrotic 
tissue surrounding the abscess. There were no Histoacryl 
deposits in the tumor.
Discussion
Endoscopic obliterative therapy with Histoacryl is useful 
for emergency control of acute gastric variceal bleeding. 
Histoacryl polymerizes immediately on contact with blood, 
resulting in rapid hemostasis. It is now the first-choice 
treatment worldwide for obliteration of bleeding gastric 
varices.2–6 The results of this study confirm that endoscopic 
injection of Histoacryl is highly effective for the treatment 
of gastric varices.
Common complications of the procedure include fever 
and chest pain due to an inflammatory response.8,9 Major 
complications of the procedure include ulceration and 
recurrent bleeding, although more serious complications, 
including embolization to the brain,10 portal vein,11 lung,12–17 
and spleen17,18 have also been reported. Other complications 
include bacteremia,19 abscesses,20,21 and development of 
visceral fistula.22
Acute and chronic inflammatory changes with Histoacryl 
include perivascular inflammation and vessel wall necrosis 
with a foreign body reaction. Perigastric abscesses may be 
induced by perivascular inflammation with infection.20,21 
Risk factors for extravariceal embolization with Histoacryl 
  treatment include a large injection volume, dilution of 
radiolucent Histoacryl with radiopaque Lipiodol, speed 
of injection, and the presence of shunts.16,23,24 In our study, 
  complications related to the procedure occurred in four 
(3.1%) patients, including two cases of splenic infarction, one 
case of pulmonary embolism, and one case of inflammatory 
tumor of the pancreatic tail.
Previously, Hwang et al evaluated the incidence of 
  pulmonary embolism following N-butyl-2-cyanoacrylate 
endoscopic treatment for bleeding gastric varices and 
  concluded that radiographically evident pulmonary 
  embolisms were uncommon, but were more likely to occur 
in patients receiving a higher volume of liquid acrylate.16 
Splenic infarction can occur when splenic vasculature is 
compromised by exposure to injected tissue adhesive agent,18 
and may be complicated by splenic vein occlusion.25 Such 
infrequent cases of splenic infarction have been shown to be 
responsive to splenic artery embolization.26,27 Inflammatory 
tumor of pancreas is a novel complication of endoscopic 
obliterative therapy with Histoacryl. Prior to surgery, we 
were unable to diagnose the inflammatory tumor accurately, 
as CT, EUS, and angiographic findings all contributed to a 
preoperative diagnosis of advanced pancreatic cancer with 
splenic vein occlusion.
To prevent Histoacryl from solidifying too quickly, 
  dilution with Lipiodol is necessary. In the cases described 
here, we used Histoacryl at a concentration of 70% in 
Lipiodol. Nonetheless, it should be noted that two of the 
risk factors for extravariceal embolization with Histoacryl 
treatment include a large injection volume, and dilution of 
radiolucent Histoacryl with radiopaque Lipiodol. Larger 
volumes of Histoacryl used for treating varices of higher 
blood volumes increase the chance of leakage, and by 
prolonging polymerization, overdilution with Lipiodol can 
increase the risk of embolizaion. To avoid embolic complica-
tions as much as possible, we recommend that endoscopists 
aim to use the smallest volume of Histoacryl necessary for 
obliteration, and to use Histoacryl in the most concentrated 
form practicable.
In conclusions, our results demonstrate the high efficacy 
and relative safety of Histoacryl used in treating gastric 
varices, but that careful attention must be paid to avoid 
potentially serious complications.
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